Journal of Pediatric Perspectives

Journal of Pediatric Perspectives

Prevalence of Pneumonia among Children Aged 4–11 Years Diagnosed with Nephrotic Syndrome and Hospitalized in Educational Therapeutic Hospitals in Urmia, Iran: A Retrospective Record-Based Study

Document Type : original article

Authors
Patient Safety Research Center, Clinical Research Institute, Nursing & Midwifery School, Urmia University of Medical Sciences, Urmia, Iran.
Abstract
Background: Children with nephrotic syndrome (NS) face increased infection risk due to immune dysregulation and immunosuppressive therapy. Pneumonia is a major cause of morbidity, but region-specific data from Iran are limited. This study aimed to determine the prevalence of pneumonia and its associated factors among hospitalized children with NS in Urmia, Iran.
Methods: A retrospective record-based study was conducted at educational therapeutic hospitals in Urmia, including children aged 4–11 years with confirmed NS hospitalized between January 1, 2020, and December 31, 2024. Pneumonia was defined using standardized World Health Organization (WHO) chest radiograph criteria, including the presence of new infiltrates, consolidation, or pleural effusion, accompanied by clinical features such as fever (≥38.0°C), tachypnea, cough, and/or oxygen desaturation. Multivariable logistic regression was used to identify factors independently associated with pneumonia.
Results: Among 206 children included in the study (median age 7.2 years; 57.3% male), the overall prevalence of radiologically confirmed pneumonia was 20.4% (95% CI: 15.1–26.6%). Community-acquired pneumonia accounted for 73.8% of cases, while nosocomial pneumonia accounted for 26.2%. The prevalence was significantly higher in children aged 4–7 years compared to those aged 8–11 years (26.8% vs. 12.8%, p=0.012) and in steroid-resistant versus steroid-sensitive NS (34.0% vs. 16.0%, p = 0.006). In multivariable analysis, after adjusting for age, sex, relapse frequency, immunosuppressive therapy, vaccination status, length of hospital stay, history of previous lower respiratory tract infection (LRTI), and seasonality, younger age (aOR per 1-year increase: 0.76; 95% CI: 0.63–0.93; p=0.006) and higher relapse frequency (aOR per additional relapse: 1.42; 95% CI: 1.12–1.81; p=0.004) remained independently associated with pneumonia. Documented pneumococcal and influenza vaccination rates were low (29.6% and 23.3%, respectively) and likely represent minimum estimates due to incomplete record-keeping.
Conclusions: Pneumonia affects one in five hospitalized children with NS in Urmia. Younger age and frequent relapses are independently associated with pneumonia in this population. Suboptimal documented vaccination coverage represents a potentially modifiable target for prevention; however, improved record-keeping is necessary to confirm true coverage rates. Clinicians should maintain a low threshold for diagnosing pneumonia and prioritize vaccination review at every healthcare encounter.
Keywords

1. Mathew G, George AS, Deepthi RV, Rose W, Verghese VP, Varghese R, et al. Epidemiology and outcomes of pneumococcal sepsis in children with nephrotic syndrome in a developing country. Pediatric Nephrology. 2023 Jan;38(1):131-7.
2. Reichel F, Tesch F, Berger S, Seifert M, Koschel D, Schmitt J, et al. Epidemiology and risk factors of community-acquired pneumonia in patients with different causes of immunosuppression. Infection. 2024 Dec;52(6):2475-86.
3. Angeletti A, Lugani F, La Porta E, Verrina E, Caridi G, Ghiggeri GM. Vaccines and nephrotic syndrome: efficacy and safety. Pediatric Nephrology. 2023 Sep;38(9):2915-28.
4. Jamali SS, Siyal AA, Iqbal M, Khan HS, Noor MS, Khan R. Incidence and Types of Infection in Children with Nephrotic Syndrome. Pakistan Journal of Medical & Cardiological Review. 2025 Jun 26;4(2):1538-152.
5. Guernsey D, Arun A, Agha R, Kupferman JC. Streptococcus pneumoniae meningitis in a child with idiopathic nephrotic syndrome: a case report. Journal of Medical Case Reports. 2022 Nov 7;16(1):403.
6. Ochoa-Gondar O, Torras-Vives V, de Diego-Cabanes C, Satué-Gracia EM, Vila-Rovira A, Forcadell-Perisa MJ, et al. Incidence and risk factors of pneumococcal pneumonia in adults: a population-based study. BMC Pulmonary Medicine. 2023 Jun 8;23(1):200.
7. Fukuda H, Onizuka H, Nishimura N, Kiyohara K. Risk factors for pneumococcal disease in persons with chronic medical conditions: Results from the LIFE Study. International Journal of Infectious Diseases. 2022 Mar 1;116:216-22.
8. Cheong D, Song JY. Pneumococcal disease burden in high-risk older adults: Exploring impact of comorbidities, long-term care facilities, antibiotic resistance, and immunization policies through a narrative literature review. Human Vaccines & Immunotherapeutics. 2024 Dec 31;20(1):2429235.
9. Sheybani F, Haddad M, Shirazinia M. Epidemiology and etiology of community-acquired CNS infections in Iran: a narrative review. Future Neurology. 2023 Dec 1;18(4):FNL73.
10. Vivarelli M, Gibson K, Sinha A, Boyer O. Childhood nephrotic syndrome. The Lancet. 2023 Sep 2;402(10404):809-24.
11. Cilloniz C, Dela Cruz CS, Dy-Agra G, Pagcatipunan Jr RS. World pneumonia day 2024: fighting pneumonia and antimicrobial resistance. American journal of respiratory and critical care medicine. 2024 Dec;210(11):1283-5.
12. Erem T, Tufan AK, Kilic O, Yilmaz AC, Kara Y, Kizil MC, et al. Pneumococcal carriage and serotype distribution in children with nephrotic syndrome. Pediatric Nephrology. 2024 Oct;39(10):2989-95.
13. Ali I, Khatri S, Kumar P, Qaiser H, Zubair A, Lanewala AA. A Frequency, Risk Factors, and Outcome of Acute Kidney Injury in Idiopathic Childhood Nephrotic Syndrome: A Systematic Review: Systematic review of Acute kidney injury in childhood nephrotic syndrome. Pakistan Journal of Kidney Diseases. 2025 Jun 30;9(2):5-15.
14. Tan HL, Yap YC, Bakar KA, Eng CSY. Healthcost and Clinical Benefits of Rituximab in Steroid Sensitive Nephrotic Syndrome: Perspective From a Middle-Income Country (MyRITUX). 2024.
15. Tilahun L, Kebede A, Ayalew Y, Gessesse AD, Kebede AG. Treatment outcome of nephrotic syndrome and associated factors among Children at Public Specialized Hospitals of Bahir Dar City, northwest, Ethiopia: Retrospective study design. 2024.
16. Tazehshahri MS, Sani AE, Helmi A, Safari M. A Large-Scale Retrospective Study on the Prevalence of COVID-19 and Urinary Bacterial Coinfections Among Hospitalized Patients in Salmas, Northwest Iran. Avicenna Journal of Clinical Microbiology and Infection. 2025 Sep 24;12(3):121-8.
17. Valavi E, Nickavar A, Amoori P, Fathi M, Valavi B. Predictive risk factors of steroid dependent nephrotic syndrome in children with idiopathic nephrotic syndrome. Journal of Nephropharmacology. 2023 Mar 18;12(2):e10571-.
18. Rodriguez-Ballestas E, Reid-Adam J. Nephrotic syndrome. Pediatrics in review. 2022 Feb 1;43(2):87-99.